|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Revenue: | |||||
| Cost of Sales | |||||
| Gross profit | |||||
| General & Administrative Expenses: | |||||
| Accounting | |||||
| Consulting | |||||
| Director fees | |||||
| Goodwill impairment | |||||
| Intangible assets impairment | |||||
| Legal | |||||
| Marketing | |||||
| Office | |||||
| Patent fees | |||||
| R&D | |||||
| Depreciation | |||||
| Salaries | |||||
| Taxes | |||||
| Depreciation & amortization | |||||
| Total General & Administrative Expenses | |||||
| (Loss) from operations | |||||
| Other Income (Expense): | |||||
| Foreign exchange gain (loss) | |||||
| Interest income | |||||
| Debt release | |||||
| Interest expense | |||||
| Gain (Loss) on asset sale | |||||
| Total Other Income (Expense) | |||||
| Net (loss) before income taxes | |||||
| Provision for income taxes | |||||
| Net (Loss) | |||||
| Gain (Loss) from foreign exchange translation | |||||
| Comprehensive (Loss) | |||||
| (Loss) per common share, Basic | |||||
| Weighted average common shares outstanding, Basic | |||||
Loading...